The United States Contraceptive Devices Market size is estimated at USD 5.12 billion in 2024, and is expected to reach USD 6.82 billion by 2029, growing at a CAGR of 5.93% during the forecast period (2024-2029).
Some of the factors such as the increasing number of unwanted pregnancies and the increasing awareness about sexually transmitted diseases (STDs) are propelling the market growth. As per the United Nations' 2019 report on contraceptive use by method, in the United States the estimated prevalence of contraceptive use among women of reproductive age (15-49 years) in 2019 was about 13.7% women used contraceptive pills, 2.3% used contraceptive injectables, 2.7% contraceptive implants, and 8.3% intrauterine contraceptive device. Women and couples are using contraceptives to have healthier pregnancies, and space births, and to achieve their desired family size. This is helping in the growth of the contraceptive devices market in the United States.
According to the U.S. Centers for Disease Control and Prevention Report, 2017, about one-third of the men or 33.7% said they used a condom the last time they had sex in the United States in 2017. This number had been reported to have increased from 29.5% in 2002, as per the report. Therefore, the increased use of condoms is expected to help the studied segment growth.
This product will be delivered within 2 business days.
Some of the factors such as the increasing number of unwanted pregnancies and the increasing awareness about sexually transmitted diseases (STDs) are propelling the market growth. As per the United Nations' 2019 report on contraceptive use by method, in the United States the estimated prevalence of contraceptive use among women of reproductive age (15-49 years) in 2019 was about 13.7% women used contraceptive pills, 2.3% used contraceptive injectables, 2.7% contraceptive implants, and 8.3% intrauterine contraceptive device. Women and couples are using contraceptives to have healthier pregnancies, and space births, and to achieve their desired family size. This is helping in the growth of the contraceptive devices market in the United States.
United States Contraceptive Devices Market Trends
Condoms are Expected to Dominate the USA Contraceptive Devices Market
A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.According to the U.S. Centers for Disease Control and Prevention Report, 2017, about one-third of the men or 33.7% said they used a condom the last time they had sex in the United States in 2017. This number had been reported to have increased from 29.5% in 2002, as per the report. Therefore, the increased use of condoms is expected to help the studied segment growth.
United States Contraceptive Devices Industry Overview
The United States Contraceptive Devices Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer Healthcare, AbbVie Inc.(Allergan), Cooper Surgical Inc., Mylan Laboratories, Pfizer Inc., Teva Pharmaceutical Industries Ltd, DKT International, Pregna International Limited, Reckitt BenckiserAdditional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.(Allergan PLC)
- Cooper Surgical Inc.
- Mylan Laboratories
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- DKT International
- Pregna International Limited
- Reckitt Benckiser
Methodology
LOADING...